Evidence map›Paper›PMID 25092787›Full record

Observational studyJournal of the American Heart Association2014

Early activation of the kynurenine pathway predicts early death and long-term outcome in patients resuscitated from out-of-hospital cardiac arrest.

Giuseppe Ristagno, Roberto Latini, Jukka Vaahersalo, Serge Masson, Jouni Kurola, Tero Varpula, Jacopo Lucchetti, Claudia Fracasso, Giovanna Guiso, Alessandro Montanelli and 6 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Journal of the American Heart Association, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Impact of heart failure on skeletal muscle: an overview.Journal of geriatric cardiology : JGC · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 2 countries.

Giuseppe RistagnoIRCCS - Istituto di Ricerche Farmacologiche "Mario Negri", Milan, Italy (G.R., R.L., S.M., J.L., C.F., G.G., S.B., M.G.).
Roberto LatiniIRCCS - Istituto di Ricerche Farmacologiche "Mario Negri", Milan, Italy (G.R., R.L., S.M., J.L., C.F., G.G., S.B., M.G.).
Jukka VaahersaloDepartment of Anesthesiology and Intensive Care Medicine, Helsinki University Central Hospital, Helsinki, Finland (J.V., T.V., V.P., M.B.S.).
Serge MassonIRCCS - Istituto di Ricerche Farmacologiche "Mario Negri", Milan, Italy (G.R., R.L., S.M., J.L., C.F., G.G., S.B., M.G.).
Jouni KurolaDepartment of Intensive Care, Kuopio University Central Hospital, Kuopio, Finland (J.K.).
Tero VarpulaDepartment of Anesthesiology and Intensive Care Medicine, Helsinki University Central Hospital, Helsinki, Finland (J.V., T.V., V.P., M.B.S.).
Jacopo LucchettiIRCCS - Istituto di Ricerche Farmacologiche "Mario Negri", Milan, Italy (G.R., R.L., S.M., J.L., C.F., G.G., S.B., M.G.).
Claudia FracassoIRCCS - Istituto di Ricerche Farmacologiche "Mario Negri", Milan, Italy (G.R., R.L., S.M., J.L., C.F., G.G., S.B., M.G.).
Giovanna GuisoIRCCS - Istituto di Ricerche Farmacologiche "Mario Negri", Milan, Italy (G.R., R.L., S.M., J.L., C.F., G.G., S.B., M.G.).
Alessandro MontanelliClinical Investigations Laboratory, Humanitas Clinical and Research Center, Milan, Italy (A.M.).
Simona BarleraIRCCS - Istituto di Ricerche Farmacologiche "Mario Negri", Milan, Italy (G.R., R.L., S.M., J.L., C.F., G.G., S.B., M.G.).
Marco GobbiIRCCS - Istituto di Ricerche Farmacologiche "Mario Negri", Milan, Italy (G.R., R.L., S.M., J.L., C.F., G.G., S.B., M.G.).
Marjaana TiainenDepartment of Neurology, Helsinki University Hospital, Helsinki, Finland (M.T.).
Ville PettiläDepartment of Anesthesiology and Intensive Care Medicine, Helsinki University Central Hospital, Helsinki, Finland (J.V., T.V., V.P., M.B.S.).
Markus B SkrifvarsDepartment of Anesthesiology and Intensive Care Medicine, Helsinki University Central Hospital, Helsinki, Finland (J.V., T.V., V.P., M.B.S.).
FINNRESUSCI Investigators
Istituti di Ricovero e Cura a Carattere Scientifico · ITHelsinki University Hospital · FIMario Negri Institute for Pharmacological Research · ITHumanitas University · ITKuopio University Hospital · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe kynurenine pathway (KP) is the major route of tryptophan (TRP) catabolism and is activated by inflammation and after cardiac arrest in animals. We hypothesized that the KP activation level correlates with severity of post-cardiac arrest shock, early death, and long-term outcome. METHODS AND

resultsPlasma was obtained from 245 patients enrolled in a prospective multicenter observational study in 21 intensive care units in Finland. Time to return of spontaneous circulation, lowest systolic arterial pressure, and bicarbonate during the first 24 hours were collected. A cerebral performance category of 3 to 5 defined 12-month poor outcome. Plasma TRP and KP metabolites, kynurenine (KYN), kynurenic acid, 3-hydroxyanthranilic acid, and the ratio of KYN to TRP were measured by liquid chromatography and mass spectrometry. All KP metabolites at intensive care unit admission were significantly higher in cardiac arrest patients with a nonshockable rhythm compared to those with a shockable rhythm, and kynurenic acid and 3-hydroxyanthranilic acid correlated with time to return of spontaneous circulation. Patients with higher levels of KYN, KYN to TRP, kynurenic acid, and 3-hydroxyanthranilic acid had lower 24-hour systolic arterial pressure and bicarbonate. All KP metabolites and the ratio of KYN to TRP, but not TRP, were significantly higher in patients who died in the intensive care unit in comparison to those who survived. Multivariable logistic regression showed that high kynurenic acid (odds ratio: 1.004; 95% confidence interval: 1.001 to 1.008; P=0.014), and 3-hydroxyanthranilic acid (odds ratio: 1.011; 95% confidence interval: 1.001 to 1.022; P=0.03) were independently associated with 12-month poor outcome and significantly improved risk reclassification.

conclusionsKP is activated early after cardiac arrest and is associated with severity of post-cardiac arrest shock, early death, and poor long-term outcome.

Indexed as

Cardiopulmonary Resuscitation3-Hydroxyanthranilic AcidAgedArterial PressureChromatography, LiquidFemaleHumansKynurenic AcidKynurenineLogistic ModelsMaleMass SpectrometryMiddle AgedOut-of-Hospital Cardiac ArrestPrognosisProspective Studies3-Hydroxyanthranilic AcidKynurenic AcidKynurenineTryptophanbraincardiac arrestkynurenineshocksurvivaltryptophan

Identifiers

PMID25092787
PMCPMC4310405
OpenAlexW2205611395

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.